18:42:56 Europe / Stockholm

Kurs & Likviditet

Kursutveckling och likviditet under dagen för detta pressmeddelande


ListaFirst North Stockholm
Scandidos är verksamma inom medicinteknik. Bolaget erbjuder produkter och system för kvalitetssäkring av avancerad strålterapi mot cancer. Systemen analyserar stråldosen inför och under pågående strålbehandling. Bolaget grundades under 2002 och den första produkten lanserades 2006. Sedan starten har Scandidos levererat produkter till strålterapikliniker på global nivå. Huvudkontoret ligger i Uppsala.


2023-06-15 Bokslutskommuniké 2023
2023-03-08 Kvartalsrapport 2023-Q3
2022-12-07 Kvartalsrapport 2023-Q2
2022-10-18 Ordinarie utdelning SDOS 0.00 SEK
2022-10-17 Årsstämma 2023
2022-09-13 Kvartalsrapport 2023-Q1
2022-06-28 Bokslutskommuniké 2022
2021-10-21 Ordinarie utdelning SDOS 0.00 SEK
2021-10-20 Årsstämma 2022
2021-09-23 Kvartalsrapport 2022-Q1
2021-06-29 Bokslutskommuniké 2021
2021-03-10 Kvartalsrapport 2021-Q3
2020-12-16 Kvartalsrapport 2021-Q2
2020-10-07 Ordinarie utdelning SDOS 0.00 SEK
2020-10-06 Årsstämma 2021
2020-09-25 Kvartalsrapport 2021-Q1
2020-06-26 Bokslutskommuniké 2020
2020-03-10 Kvartalsrapport 2020-Q3
2019-12-18 Kvartalsrapport 2020-Q2
2019-10-09 Ordinarie utdelning SDOS 0.00 SEK
2019-10-08 Årsstämma 2020
2019-09-12 Kvartalsrapport 2020-Q1
2019-06-28 Bokslutskommuniké 2019
2018-12-14 Kvartalsrapport 2019-Q2
2018-10-03 Ordinarie utdelning SDOS 0.00 SEK
2018-10-02 Årsstämma 2019
2018-06-28 Bokslutskommuniké 2018
2018-03-22 Kvartalsrapport 2018-Q3
2017-12-15 Kvartalsrapport 2018-Q2
2017-10-03 Ordinarie utdelning SDOS 0.00 SEK
2017-10-02 Årsstämma 2018
2017-09-29 Kvartalsrapport 2018-Q1
2017-06-28 Bokslutskommuniké 2017
2017-03-22 Kvartalsrapport 2017-Q3
2016-12-15 Kvartalsrapport 2017-Q2
2016-09-21 Ordinarie utdelning SDOS 0.00 SEK
2016-09-20 Kvartalsrapport 2017-Q1
2016-09-20 Årsstämma 2017
2016-06-30 Bokslutskommuniké 2016
2016-03-15 Kvartalsrapport 2016-Q3
2015-12-11 Kvartalsrapport 2016-Q2
2015-09-24 Ordinarie utdelning SDOS 0.00 SEK
2015-09-23 Kvartalsrapport 2016-Q1
2015-09-23 Årsstämma 2016
2015-06-23 Bokslutskommuniké 2015
2015-03-26 Kvartalsrapport 2015-Q3
2014-12-19 Kvartalsrapport 2015-Q2
2014-10-14 Årsstämma 2015
2014-09-24 Ordinarie utdelning SDOS 0.00 SEK
2014-09-23 Kvartalsrapport 2015-Q1
2014-06-13 Bokslutskommuniké 2014
2022-02-16 08:00:00

ScandiDos has reached an exciting milestone in the fight against cancer as the company celebrates 20 years of success as the leading provider of patient specific QA solutions. In addition to reaching 20 years in business, ScandiDos also reached another important milestone – over 1000 delivered Delta4 systems!

For the last two decades, ScandiDos has been at the forefront of innovation in modern radiation therapy, developing software and hardware solutions for patient specific quality assurance (QA). Delivering the Delta4 Family of QA solutions to radiotherapy clinics and hospitals worldwide, ScandiDos ensures that cancer patients receive safe and accurate treatments. Looking back on these years, ScandiDos is proud to have taken patient QA from 2D to 4D, from wires to Wi-Fi, from high maintenance to stability while expanding its global footprint with offices in Sweden, the US, France, Malaysia and China.

ScandiDos´ purpose has always been to support medical physicists with the tools and confidence they need to ensure clinical efficiency, accuracy, and patient safety. A purpose that is further growing in importance due to the use of new treatment techniques such as hypofractionation and adaptive radiotherapy. When radiotherapy clinics invest in new technologies, ScandiDos provide them with equally advanced and efficient QA solutions.

In connection to the 20th anniversary ScandiDos has reached a milestone of over 1 000 delivered Delta4 systems worldwide and counting. This is a great achievement and proof of the company´s ability to provide radiotherapy clinics with the most accurate and effective QA solutions. Over the years, ScandiDos has significantly diversified its offerings to become more adaptive to different treatment techniques and it is today the leading provider of patient safety QA for the most advanced treatment machines such as Accuray Radixact with Synchrony, Varian Halcyon, Elekta Unity and Viewray MRIdian.

ScandiDos continual momentum to enhance its products and offers reflects the company’s ongoing commitment to solve industry challenges through innovation and user commitment.

“While we are proud of our progress as a company over the past couple decades, we are most proud of what our technology has done in the hands of medical physicists. We are grateful that our solutions have been key contributors in ensuring that so many cancer patients have been treated accurately and safely said Gustaf Piehl, CEO. “To everyone who has been a part of our journey in reaching these milestones, we would like to share this success and thank each of you for being there with us along the way!”